dromlakhani Interpret LDL cholesterol for dyslipidemia screening
STEP 1 — Gather Information
Collect patient age, BMI percentile (using CDC norms), fasting lipid panel (LDL, HDL, triglycerides, total cholesterol), fasting status, and family history of premature cardiovascular disease or dyslipidemia.
STEP 2 — Rule In / Rule Out
Is the patient aged 2–19 years with BMI ≥85th percentile? If yes, proceed to lipid screening; if no, routine dyslipidemia screening is not indicated per guideline.
STEP 3 — Classify or Stratify
Classify LDL cholesterol: <110 mg/dL acceptable, 110–129 mg/dL borderline high, ≥130 mg/dL high.
STEP 4 — Decide
If acceptable, repeat lipid panel in 2 years if risk persists; if borderline high, reinforce therapeutic lifestyle changes and recheck in 1 year; if high, intensify lifestyle intervention, reassess in 3–6 months, and consider referral to lipid specialist or pharmacotherapy if LDL remains ≥130 mg/dL after lifestyle trial.
Clinical Guardrails / Mimics / Pitfalls
Do not use non-fasting LDL for classification; avoid screening during acute illness or inflammation; LDL may be falsely elevated in nephrotic syndrome, hypothyroidism, or cholestasis; always interpret alongside HDL and triglycerides; familial hypercholesterolemia may present with LDL ≥190 mg/dL and requires genetic evaluation.
Concrete Clinical Example
A 12‑year‑old with BMI at the 98th percentile has a fasting LDL of 135 mg/dL (high). Lifestyle intervention is intensified; LDL is rechecked in 3 months and falls to 118 mg/dL (borderline high), prompting continued lifestyle focus.
Source: Pediatric Obesity Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline, Styne et al., 2017, doi:10.1210/jc.2016-2573
TODO: consider adding scripts/calc.py for the eso-pediatric-obesity-ldl-interpretation calculator